European Medicines Agency starts first rolling review of a COVID-19 vaccine in the EU

A rolling review is used to speed up the assessment of a promising medicine or vaccine during a public health emergency. The CHMP has started evaluating the first batch of data (non-clinical) on the vaccine being developed by AstraZeneca and the University of Oxford.

Source:

European Medicines Agency